Categories
Laurus Labs Limited — Updates, 30-04-2026: General Updates
30-04-2026 · 03:20 pm
Board approved new independent directors. It cleared €9.8M investment in JV KRKA Pharma for a manufacturing facility (KRKA FY26 turnover: ₹1.047 Cr). A non-material German subsidiary (net worth: €(1,053,091)) will be closed. An independent director also retired.
No comments yet. Be the first to comment!